These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [Abstract] [Full Text] [Related]
4. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients. Okin PM. J Electrocardiol; 2009 May; 42(6):584-8. PubMed ID: 19631946 [Abstract] [Full Text] [Related]
5. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study. Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C. J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174 [Abstract] [Full Text] [Related]
6. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram. Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB. Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375 [Abstract] [Full Text] [Related]
7. Hypertension and Organ Damage in Women. Muiesan ML, Paini A, Aggiusti C, Bertacchini F, Rosei CA, Salvetti M. High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358 [Abstract] [Full Text] [Related]
9. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]. Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND. Ter Arkh; 2007 Sep; 79(6):34-40. PubMed ID: 17684964 [Abstract] [Full Text] [Related]
10. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison. Nardi E, Mulè G, Giammanco A, Mattina A, Geraci G, Nardi C, Averna M. Nutr Metab Cardiovasc Dis; 2021 Jan 04; 31(1):137-144. PubMed ID: 33092976 [Abstract] [Full Text] [Related]
11. Left ventricular hypertrophy in nondiabetic predialysis CKD. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Am J Kidney Dis; 2005 Aug 04; 46(2):320-7. PubMed ID: 16112052 [Abstract] [Full Text] [Related]
12. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. Ravera M, Noberasco G, Signori A, Re M, Filippi A, Cannavò R, Weiss U, Cricelli C, Deferrari G, Paoletti E. Am J Hypertens; 2013 May 04; 26(5):700-7. PubMed ID: 23391620 [Abstract] [Full Text] [Related]
13. Why is cardiovascular risk stratification important in hypertensive patients? Coll-De-Tuero G, Saez M, Rodriguez-Poncelas A, Barceló-Rado A, Vargas-Vila S, Garre-Olmo J, Sala V, Sieira A, Gelada E, Gelado-Ferrero J. Blood Press; 2012 Jun 04; 21(3):182-90. PubMed ID: 22486493 [Abstract] [Full Text] [Related]
14. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate]. Grabysa R, Cholewa M. Pol Merkur Lekarski; 2008 Oct 04; 25(148):309-14. PubMed ID: 19145927 [Abstract] [Full Text] [Related]
15. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A. Clin Exp Nephrol; 2013 Oct 04; 17(5):730-742. PubMed ID: 23318981 [Abstract] [Full Text] [Related]
16. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study. Muiesan ML, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Salvetti M, Trimarco B, Volpe M, Pontremoli R, Deferrari G, Rosei EA. J Hypertens; 2012 Dec 04; 30(12):2378-86. PubMed ID: 23137952 [Abstract] [Full Text] [Related]
17. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T. Hypertens Res; 2009 Dec 04; 32(12):1123-9. PubMed ID: 19816503 [Abstract] [Full Text] [Related]
18. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A. Clin Exp Nephrol; 2019 Jan 04; 23(1):85-98. PubMed ID: 29951723 [Abstract] [Full Text] [Related]
19. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease. Chang JM, Chen SC, Huang JC, Su HM, Chen HC. Am J Med Sci; 2014 Mar 04; 347(3):183-9. PubMed ID: 23426086 [Abstract] [Full Text] [Related]
20. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Mallamaci F, Minutolo R, Leonardis D, D'Arrigo G, Tripepi G, Rapisarda F, Cicchetti T, Maimone I, Enia G, Postorino M, Santoro D, Fuiano G, De Nicola L, Conte G, Zoccali C. Kidney Int; 2013 Aug 04; 84(2):381-9. PubMed ID: 23615498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]